Clinical trial Recruiting at 1 site Interventional Ages 2 to 18

Combining botulinum toxin and shockwave therapy for spasticity in children with cerebral palsy

Official title: The Effects of Botulinum Toxin Type a Injection Combined with RESWT in Lower Extremity Spasticity in Children with Cerebral Palsy

Run by Istanbul Medeniyet University · NCT06494618 · Data updated 2026-11-12

This study is testing if combining botulinum toxin injections with shockwave therapy can help reduce muscle tightness and improve movement in children with cerebral palsy.

Quick facts

Study typeInterventional
Ages2 Years to 18 Years
SexAll
Enrollment20 (estimated)
SponsorIstanbul Medeniyet University
Academic / other
Locations1 site (Istanbul, Kadikoy)
StatusRecruiting
StartedMarch 2025
Main results expectedMay 2025
Study endsJune 2025
Registry record updatedMarch 11, 2025
Trial IDNCT06494618 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children diagnosed with cerebral palsy who exhibit spasticity in their lower extremities and have received botulinum toxin injections.

Probably not a fit

Patients with a history of recent surgery on the targeted muscle, uncontrolled epilepsy, infections, or coagulopathy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of combining botulinum toxin type A injections with extracorporeal shockwave therapy on lower extremity spasticity in children diagnosed with cerebral palsy. A total of 20 pediatric patients will be divided into two groups: one receiving only conventional treatment post-injection and the other receiving shockwave therapy in addition to the injection. The study will evaluate various outcomes, including muscle tone, joint range of motion, and functional mobility, at multiple time points following treatment.

Why it matters

Potential benefit: If successful, this approach could significantly improve mobility and quality of life for children with cerebral palsy by reducing spasticity more effectively than standard treatment alone.

How similar studies have gone: While the combination of botulinum toxin and shockwave therapy is a novel approach, similar studies have shown promise in treating spasticity with either method alone.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosed with cerebral palsy.
* Spasticity in at least one of the lower extremity muscle groups.
* No contraindications to shockwave therapy.
* Applied Botulinum Toxin Type A injection for at least one spastic muscle of lower extremity.
* Agreed to participate to study (patient/primary caregiver)

Exclusion Criteria:

* Surgery history within the last year of the muscle to be injected and treated
* Having uncontrolled epilepsy.
* Having infection
* Coagulopathy

Where it's running

  • Istanbul Medeniyet University Goztepe Prof. Dr. Suleyman Yalcin City Hospital
    Istanbul, Kadikoy, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.